JAGSNPHARM logo

Jagsonpal Pharmaceuticals Limited Stock Price

NSEI:JAGSNPHARM Community·₹13.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

JAGSNPHARM Share Price Performance

₹0
-268.40 (-100.00%)
₹0
-268.40 (-100.00%)
Price ₹0

JAGSNPHARM Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with solid track record and pays a dividend.

1 Risk
3 Rewards

Jagsonpal Pharmaceuticals Limited Key Details

₹2.8b

Revenue

₹1.0b

Cost of Revenue

₹1.8b

Gross Profit

₹1.2b

Other Expenses

₹619.4m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
9.28
63.59%
21.91%
0%
View Full Analysis

About JAGSNPHARM

Founded
1978
Employees
1399
CEO
Manish Gupta
WebsiteView website
www.jagsonpal.com

Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. Jagsonpal Pharmaceuticals Limited was incorporated in 1978 and is based in Gurugram, India.

Recent JAGSNPHARM News & Updates

We Think Shareholders Should Be Aware Of Some Factors Beyond Jagsonpal Pharmaceuticals' (NSE:JAGSNPHARM) Profit

Nov 13
We Think Shareholders Should Be Aware Of Some Factors Beyond Jagsonpal Pharmaceuticals' (NSE:JAGSNPHARM) Profit

Recent updates

No updates